Evidence map›Paper›PMID 36834893›Full record

ArticleInternational journal of molecular sciences2023

Comparative Analysis of Retinal Organotypic Cultures and In Vivo Axotomized Retinas.

María José González-Riquelme, Fernando Lucas-Ruiz, Caridad Galindo-Romero, Raquel Boia, António Francisco Ambrósio, Manuel Vidal-Sanz, Ana Raquel Santiago, Marta Agudo-Barriuso

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Transcriptomic Analysis of Organotypic Porcine Retina Cultures.International journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

María José González-RiquelmeExperimental Ophthalmology Group, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca) & Universidad de Murcia, 30120 Murcia, Spain.
Fernando Lucas-RuizExperimental Ophthalmology Group, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca) & Universidad de Murcia, 30120 Murcia, Spain.ORCID 0000-0002-8799-6909
Caridad Galindo-RomeroExperimental Ophthalmology Group, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca) & Universidad de Murcia, 30120 Murcia, Spain.ORCID 0000-0001-9469-9868
Raquel BoiaUniversity of Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, 3000-548 Coimbra, Portugal.ORCID 0000-0002-0479-3066
António Francisco AmbrósioUniversity of Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, 3000-548 Coimbra, Portugal.ORCID 0000-0002-0477-1641
Manuel Vidal-SanzExperimental Ophthalmology Group, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca) & Universidad de Murcia, 30120 Murcia, Spain.ORCID 0000-0002-9216-1615
Ana Raquel SantiagoUniversity of Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, 3000-548 Coimbra, Portugal.ORCID 0000-0002-7541-7041
Marta Agudo-BarriusoExperimental Ophthalmology Group, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca) & Universidad de Murcia, 30120 Murcia, Spain.ORCID 0000-0002-8566-9277
Instituto Murciano de Investigación Biosanitaria · ESEscola Superior de Tecnologia da Saúde de Coimbra · PT

Funding

Centro2020 Regional Operational Programme CENTRO-01-0145-FEDER-000008: BrainHealth 2020FCT-Portugal UIDB/04539/2020Fundación Séneca, Agencia de Ciencia y Tecnología Región de Murcia 19881/GERM/15Instituto de Salud Carlos III, Fondo Europeo de Desar-rollo Regional "Una manera de hacer Europa" PI19/00071Spanish Ministry of Economy and Competitiveness PID2019-106498GB-I00
6 · The paper itself

Abstract

Retinal organotypic cultures (ROCs) are used as an in vivo surrogate to study retinal ganglion cell (RGC) loss and neuroprotection. In vivo, the gold standard to study RGC degeneration and neuroprotection is optic nerve lesion. We propose here to compare the course of RGC death and glial activation between both models. The left optic nerve of C57BL/6 male mice was crushed, and retinas analyzed from 1 to 9 days after the injury. ROCs were analyzed at the same time points. As a control, intact retinas were used. Retinas were studied anatomically to assess RGC survival, microglial, and macroglial activation. Macroglial and microglial cells showed different morphological activation between models and were activated earlier in ROCs. Furthermore, microglial cell density in the ganglion cell layer was always lower in ROCs than in vivo. RGC loss after axotomy and in vitro followed the same trend up to 5 days. Thereafter, there was an abrupt decrease in viable RGCs in ROCs. However, RGC somas were still immuno-identified by several molecular markers. ROCs are useful for proof-of-concept studies on neuroprotection, but long-term experiments should be carried out in vivo. Importantly, the differential glial activation observed between models and the concomitant death of photoreceptors that occurs in vitro may alter the efficacy of RGC neuroprotective therapies when tested in in vivo models of optic nerve injury.

Indexed as

Microphysiological SystemsOptic Nerve InjuriesAnimalsAxotomyCell SurvivalMaleMiceMice, Inbred C57BLRetinaRetinal Ganglion Cellsastrocytesaxotomyin vitroin vivomicrogliaMüller cellsretinal ganglion cells

Identifiers

PMID36834893
PMCPMC9962025
OpenAlexW4319985312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.